Skip to main content
. Author manuscript; available in PMC: 2014 Jun 24.
Published in final edited form as: Biol Blood Marrow Transplant. 2009 Sep 1;15(11):1431–1438. doi: 10.1016/j.bbmt.2009.07.008

Figure 1.

Figure 1

Flow chart of patient treatments. Of 599 evaluable patients, 67 died during 1st salvage chemotherapy and 42 underwent HSCT as their 1st salvage therapy (both shown in gray boxes). These groups were not used in this analysis. The remaining 490 patients were evaluable of whom 112 patients achieved CR (378 did not). After 1st salvage therapy 94 patients did not undergo further treatment (shown in gray box) and were subsequently excluded from further analysis leaving 396 patients for analysis.